Saudi Arabia’s research antibodies market to be valued at $12.71m by 2030

A focus on disease prevention and personalised medicine is driving growth.

Saudi Arabia’s research antibodies market is projected to hit $12.71m by 2030 at a compound annual growth rate of 3.4%, according to Research and Markets.

The sector’s expansion is attributed to the growth of the life sciences sector, increased research and development investments, and an increased focus on biomedical research.

“Research antibodies, essential tools in molecular biology, immunology, and biochemistry, are becoming vitally important for detecting, analysing, and quantifying proteins and biological molecules,” the report said.

Moreover, the focus on disease prevention and personalised medicine is driving market growth.

However, expensive antibody costs pose challenges, particularly for specialised applications.

“The complexity involved in developing, producing, and controlling the quality of these antibodies results in high costs, impacting research budgets of academic institutions and biotech companies,” it added.

Reliance on imported antibodies increased costs through shipping fees, import taxes, and currency fluctuations, making advanced research tools less accessible.